Home / Health / PetMed CFO says allegations of marketing to opioid addicts are ‘bogus’

PetMed CFO says allegations of marketing to opioid addicts are ‘bogus’

A short seller’s allegations that PetMed Express markets pet medicine to human opioid addicts are “bogus,” PetMed Chief Financial Officer Bruce Rosenbloom told Reuters on Wednesday.

PetMed’s stock slumped 17 percent on Wednesday following the release of a report by Aurelius Value, which said it has shorted the shares. The report alleges that PetMed deliberately targets opioid addicts in its online marketing for pet pain killers.

About admin

Check Also

Bad blood over Obamacare fight lingers as Congress returns

When the U.S. Congress returns from summer vacation on Tuesday, for the first time in …

Leave a Reply

Your email address will not be published. Required fields are marked *

error: Content is protected !!